日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Human APE2 and TREX2 Repair 3'-DNA-Peptide Cross-links Derived from Abasic Sites

人类 APE2 和 TREX2 修复源自无碱基位点的 3'-DNA-肽交联

期刊:Chemical Research in Toxicology
影响因子:3.8
doi:10.1021/acs.chemrestox.5c00398
Wei, Xiaoying; Cepeda, Joel; Chung, Jee Min; Lee, Sang Eun; Yang, Kun
Human
发表日期：2025
文献求助 收藏

Anti-TCP1 Antibody Is a Potential Biomarker for Diagnosing Systemic Lupus Erythematosus

抗TCP1抗体是诊断系统性红斑狼疮的潜在生物标志物

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms25168612
Lee, Sang-Won; Baek, Wook-Young; Park, So-Won; Chung, Jee-Min; Park, Ji-Hyun; Kang, Ho Chul; Jung, Ju-Yang; Suh, Chang-Hee
红斑狼疮
免疫/内分泌
发表日期：2024
文献求助 收藏

USP39 promotes non-homologous end-joining repair by poly(ADP-ribose)-induced liquid demixing

USP39通过聚（ADP-核糖）诱导的液相分离促进非同源末端连接修复

期刊:Nucleic Acids Research
影响因子:13.1
doi:10.1093/nar/gkab892
Kim, Jae Jin; Lee, Seo Yun; Hwang, Yiseul; Kim, Soyeon; Chung, Jee Min; Park, Sangwook; Yoon, Junghyun; Yun, Hansol; Ji, Jae-Hoon; Chae, Sunyoung; Cho, Hyeseong; Kim, Chan Gil; Dawson, Ted M; Kim, Hongtae; Dawson, Valina L; Kang, Ho Chul
相分离
SP3
发表日期：2021
文献求助 收藏

A Novel Reciprocal Crosstalk between RNF168 and PARP1 to Regulate DNA Repair Processes

RNF168和PARP1之间一种新型的相互串扰机制，通过这种机制调控DNA修复过程

期刊:Molecules and Cells
影响因子:6.5
doi:10.14348/molcells.2018.0078
Kim, Jae Jin; Lee, Seo Yun; Kim, Soyeon; Chung, Jee Min; Kwon, Mira; Yoon, Jung Hyun; Park, Sangwook; Hwang, Yiseul; Park, Dongsun; Lee, Jong-Soo; Kang, Ho Chul
信号转导
NF1
PARP1
PARP
发表日期：2018
文献求助 收藏

Identification of the Thioredoxin-Like 2 Autoantibody as a Specific Biomarker for Triple-Negative Breast Cancer

鉴定硫氧还蛋白样2自身抗体为三阴性乳腺癌的特异性生物标志物

期刊:Journal of Breast Cancer
影响因子:2.4
doi:10.4048/jbc.2018.21.1.87
Chung, Jee Min; Jung, Yongsik; Kim, Young Pil; Song, Jinsue; Kim, Soyeon; Kim, Ji Young; Kwon, Mira; Yoon, Jung Hyun; Kim, Myo-Deok; Lee, Jun-Kyoung; Chung, Da-Yoon; Lee, Seo Yun; Kang, Jooseong; Kang, Ho Chul
肿瘤
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2018
文献求助 收藏

Effective therapeutic approach for head and neck cancer by an engineered minibody targeting the EGFR receptor.

利用靶向 EGFR 受体的工程化微型抗体，对头颈癌进行有效治疗

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0113442
Kim Young Pil, Park Dongsun, Kim Jae Jin, Chi Won-Jae, Lee Sun Hee, Lee Seo Yun, Kim Soyeon, Chung Jee Min, Jeon Jinseon, Lee Byoung Dae, Shin Joo-Ho, Lee Yun-Il, Cho Hyeseong, Lee Jeong-Min, Kang Ho Chul
肿瘤
EGFR
发表日期：2014
文献求助 收藏